lobbying_activities: 2350133

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2350133	021e5079-612e-48fd-bb08-0f1ea6df6f4b	Q3	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	3457	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	2019	third_quarter	PHA	Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Support for S. 340/H.R. 965, Creating and Restoring Equal Access to Equivalent Samples Act of 2019. Conversation with DEA regulation on Medication-Assisted Treatment and drug shortages.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE		350000	0	0	2019-10-18T10:53:08.447000-04:00